- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 515/18 - Bridged systems
Patent holdings for IPC class C07D 515/18
Total number of patents in this class: 77
10-year publication summary
|
1
|
1
|
1
|
1
|
2
|
3
|
7
|
9
|
5
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Vertex Pharmaceuticals Incorporated | 1600 |
7 |
| Genzyme Corporation | 1262 |
5 |
| Janssen Pharmaceutica N.V. | 3394 |
3 |
| CTI Biopharma Corp. | 35 |
3 |
| Elanco Animal Health Ireland Limited | 3 |
3 |
| Les Laboratoires Servier | 537 |
3 |
| Oncodesign S.A. | 15 |
3 |
| Polyphor AG | 87 |
3 |
| Inflazome Limited | 85 |
3 |
| Sionna Therapeutics, Inc. | 15 |
3 |
| Novartis AG | 10744 |
2 |
| Atrin Pharmaceuticals LLC | 8 |
2 |
| Istituto Nazionale di Genetica Molecolare-ingm | 24 |
2 |
| Janssen Sciences Ireland UC | 183 |
2 |
| Ospedale San Raffaele S.r.l. | 277 |
2 |
| S*BIO Pte Ltd. | 25 |
2 |
| Captor Therapeutics S.A. | 26 |
2 |
| Irbm S.p.A. | 23 |
2 |
| Sionna Therapeutics | 5 |
2 |
| Takeda Pharmaceutical Company Limited | 2708 |
1 |
| Other owners | 22 |